BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND DDX5, HLR1, 1655, ENSG00000108654, P17844, DKFZp686J01190, p68, G17P1, HUMP68
28 results:

  • 1. Role of the DEAD-box RNA helicase ddx5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human microbiome (microbiota) negative influence.
    Li F; Ling X; Chakraborty S; Fountzilas C; Wang J; Jamroze A; Liu X; Kalinski P; Tang DG
    J Exp Clin Cancer Res; 2023 Aug; 42(1):213. PubMed ID: 37596619
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer.
    Seltzer S; Giannopoulos PN; Bismar TA; Trifiro M; Paliouras M
    Asian J Androl; 2023; 25(3):296-308. PubMed ID: 36259569
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Guidelines for Sexual Health Care for prostate cancer Patients: Recommendations of an International Panel.
    Wittmann D; Mehta A; McCaughan E; Faraday M; Duby A; Matthew A; Incrocci L; Burnett A; Nelson CJ; Elliott S; Koontz BF; Bober SL; McLeod D; Capogrosso P; Yap T; Higano C; Loeb S; Capellari E; Glodé M; Goltz H; Howell D; Kirby M; Bennett N; Trost L; Odiyo Ouma P; Wang R; Salter C; Skolarus TA; McPhail J; McPhail S; Brandon J; Northouse LL; Paich K; Pollack CE; Shifferd J; Erickson K; Mulhall JP
    J Sex Med; 2022 Nov; 19(11):1655-1669. PubMed ID: 36192299
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ddx5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.
    Le TK; Cherif C; Omabe K; Paris C; Lannes F; Audebert S; Baudelet E; Hamimed M; Barbolosi D; Finetti P; Bastide C; Fazli L; Gleave M; Bertucci F; Taïeb D; Rocchi P
    Mol Ther; 2023 Feb; 31(2):471-486. PubMed ID: 35965411
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical application of free/total PSA ratio in the diagnosis of prostate cancer in men over 50 years of age with total PSA levels of 2.0-25.0 ng ml
    Gao XD; Miao Q; Zhang JL; Zhai JZ; Gui XM; Cai YH; Niu Q; Cai B
    Asian J Androl; 2022; 24(2):195-200. PubMed ID: 34916475
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sexual rehabilitation recommendations for prostate cancer survivors and their partners from a biopsychosocial prostate cancer Supportive Care Program.
    Yuen W; Witherspoon L; Wu E; Wong J; Sheikholeslami S; Bentley J; Zarowski C; Sundar M; Elliott S; Higano C; Flannigan R
    Support Care Cancer; 2022 Feb; 30(2):1853-1861. PubMed ID: 34613474
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Wnt activator FOXB2 drives the neuroendocrine differentiation of prostate cancer.
    Moparthi L; Pizzolato G; Koch S
    Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22189-22195. PubMed ID: 31611391
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. LncRNA CCAT1 Promotes prostate cancer Cell Proliferation by Interacting with ddx5 and MIR-28-5P.
    You Z; Liu C; Wang C; Ling Z; Wang Y; Wang Y; Zhang M; Chen S; Xu B; Guan H; Chen M
    Mol Cancer Ther; 2019 Dec; 18(12):2469-2479. PubMed ID: 31387890
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ddx5/p68 associated lncRNA LOC284454 is differentially expressed in human cancers and modulates gene expression.
    Das M; Renganathan A; Dighe SN; Bhaduri U; Shettar A; Mukherjee G; Kondaiah P; Satyanarayana Rao MR
    RNA Biol; 2018 Feb; 15(2):214-230. PubMed ID: 29227193
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Independent Pre-Transplant Recipient cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control.
    Schrem H; Schneider V; Kurok M; Goldis A; Dreier M; Kaltenborn A; Gwinner W; Barthold M; Liebeneiner J; Winny M; Klempnauer J; Kleine M
    PLoS One; 2016; 11(7):e0158732. PubMed ID: 27398803
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Resveratrol directly targets ddx5 resulting in suppression of the mTORC1 pathway in prostate cancer.
    Taniguchi T; Iizumi Y; Watanabe M; Masuda M; Morita M; Aono Y; Toriyama S; Oishi M; Goi W; Sakai T
    Cell Death Dis; 2016 May; 7(5):e2211. PubMed ID: 27148684
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Commentary on: "Long-term functional outcomes after treatment for localized prostate cancer." Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Potosky AL, Stanford JL, Stroup AM, Van Horn RL, Penson DF. Department of Urologic Surgery and the Center for Surgical Quality and Outcomes Research, Vanderbilt University, Nashville, TN.: N Engl J Med 2013;368(5):436-45. doi: 10.1056/NEJMoa1209978.
    Eggener S
    Urol Oncol; 2014 May; 32(4):513-4. PubMed ID: 24767688
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells.
    Iio A; Takagi T; Miki K; Naoe T; Nakayama A; Akao Y
    Biochim Biophys Acta; 2013 Oct; 1829(10):1102-10. PubMed ID: 23932921
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Favourable long-term outcomes with brachytherapy-based regimens in men ≤60 years with clinically localized prostate cancer.
    Kollmeier MA; Fidaleo A; Pei X; Cohen G; Zaider M; Mo Q; Cox B; Yamada Y; Zelefsky MJ
    BJU Int; 2013 Jun; 111(8):1231-6. PubMed ID: 23551568
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long-term functional outcomes after treatment for localized prostate cancer.
    Resnick MJ; Koyama T; Fan KH; Albertsen PC; Goodman M; Hamilton AS; Hoffman RM; Potosky AL; Stanford JL; Stroup AM; Van Horn RL; Penson DF
    N Engl J Med; 2013 Jan; 368(5):436-45. PubMed ID: 23363497
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. p68/ddx5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.
    Clark EL; Hadjimichael C; Temperley R; Barnard A; Fuller-Pace FV; Robson CN
    PLoS One; 2013; 8(1):e54150. PubMed ID: 23349811
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PDGF upregulates Mcl-1 through activation of β-catenin and HIF-1α-dependent signaling in human prostate cancer cells.
    Iqbal S; Zhang S; Driss A; Liu ZR; Kim HR; Wang Y; Ritenour C; Zhau HE; Kucuk O; Chung LW; Wu D
    PLoS One; 2012; 7(1):e30764. PubMed ID: 22276222
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Time dependence of cellular chemical changes induced in prostate PC-3 cancer cells by two structurally related cardenolides monitored by Fourier transform infrared (FT-IR) spectroscopy.
    Gasper R; Mijatovic T; Kiss R; Goormaghtigh E
    Appl Spectrosc; 2011 Jun; 65(6):584-94. PubMed ID: 21639979
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Resonant Mie scattering (RMieS) correction of infrared spectra from highly scattering biological samples.
    Bassan P; Kohler A; Martens H; Lee J; Byrne HJ; Dumas P; Gazi E; Brown M; Clarke N; Gardner P
    Analyst; 2010 Feb; 135(2):268-77. PubMed ID: 20098758
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer.
    Clark EL; Coulson A; Dalgliesh C; Rajan P; Nicol SM; Fleming S; Heer R; Gaughan L; Leung HY; Elliott DJ; Fuller-Pace FV; Robson CN
    Cancer Res; 2008 Oct; 68(19):7938-46. PubMed ID: 18829551
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.